It is probably too early to categorically declare that Covid-19 has been beaten. But on the day that we emerge from Lockdown 2, news that Pfizer’s vaccine has been approved for use in the UK will surely have lifted the nation’s spirits – even if the market’s reaction was more muted than it had been previously on news of trial results.
Ready to join us? Start with a free account
Become a registered user today and enjoy:
- 3 free full-length articles every month
- Weekly editorial newsletters providing the latest market updates
- investment tools to help you manage your portfolio
- In-depth podcasts on topics that matter to your money